QianHai Equity Investment
VC Fund
Shenzhen, China
QianHai Equity Investment is a VC fund in Shenzhen focused on Medical and Food and Beverage. QianHai Equity Investment invests in direct and fund of fund investments.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries QianHai Equity Investment invests in
Stages QianHai Equity Investment invests in
Countries QianHai Equity Investment invests in
Investment Focus
Industry
- Medical 2 (50%)
- Food and Beverage 2 (50%)
- Chemical 1 (25%)
- Agriculture 1 (25%)
- Health Care 1 (25%)
Stage
- Series A 2 (50%)
- Series B 1 (25%)
- Series C 1 (25%)
Country
- China 3 (75%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sichuan Baijia Food
|
Sichuan Baijia Food is a food company. | $15.6M / Series A / Feb 19, 2020 | |
Baijia Food
|
Baijia Food is an agricultural product processing demonstration enterprise. | $15.7M / Series A / Feb 19, 2020 | |
Bellen
|
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent trackrecords, as we deliver unrivalled chemical innovation to our customers worldwide. | $30M / Series C / Sep 27, 2018 | |
Ascletis
|
Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China'scapital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases. | $100M / Series B / Jan 03, 2017 |
Co-Investors
Cowin Capital
2 deals together
Apricot Capital
1 deal together
C-Bridge Capital
1 deal together
Focus Media
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does QianHai Equity Investment invest in?
QianHai Equity Investment invests primarily in Medical, Food and Beverage and Chemical startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did QianHai Equity Investment last invest?
The most recent investment recorded for QianHai Equity Investment closed in Feb 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
